PainReform LtdNASDAQ:PRFXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4600
- TODAY'S CHANGE (%)-0.0200 (-4.1667%)
- Bid / Lots0.4202/ 1
- Ask / Lots0.5200/ 5
- Open / Previous Close0.4600 / 0.4800
- Day Range
- 52 Week Range
- Volume70,943
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRFX |
|---|---|---|
| 09:32 ET | 27744 | 0.44 |
| 09:34 ET | 400 | 0.4771 |
| 09:54 ET | 2001 | 0.45 |
| 09:59 ET | 249 | 0.45 |
| 10:14 ET | 600 | 0.46 |
| 10:15 ET | 300 | 0.46 |
| 10:17 ET | 4354 | 0.478 |
| 10:30 ET | 500 | 0.479899 |
| 10:50 ET | 2785 | 0.46 |
| 10:53 ET | 200 | 0.46 |
| 11:04 ET | 400 | 0.46 |
| 11:56 ET | 208 | 0.47 |
| 12:50 ET | 600 | 0.47 |
| 12:56 ET | 100 | 0.469999 |
| 02:11 ET | 2000 | 0.4699 |
| 02:15 ET | 8141 | 0.47 |
| 02:44 ET | 100 | 0.46 |
| 03:38 ET | 8150 | 0.47 |
| 03:39 ET | 2850 | 0.47 |
| 03:48 ET | 200 | 0.47 |
| 03:59 ET | 500 | 0.46 |
Yesterday
BRIEF-Painreform Ltd Says Company's Supplier Of API Has Received A Deficiency Notice From FDA Related To Its Drug Master File, from 5:25PM ET on Wednesday Jun 07, 2023 by Thomson Reuters
5:25PM ET on Wednesday Jun 07, 2023 by Thomson ReutersPainReform's Second Part of Phase 3 Trial of PRF-110 Faces Potential Delay, from 5:07PM ET on Wednesday Jun 07, 2023 by MT Newswires
5:07PM ET on Wednesday Jun 07, 2023 by MT NewswiresPainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery, from 4:30PM ET on Wednesday Jun 07, 2023 by GlobeNewswire
4:30PM ET on Wednesday Jun 07, 2023 by GlobeNewswire
May 18, 2023
May 15, 2023
BRIEF-Painreform Provides Business Update For The First Quarter Of 2023, from 5:44PM ET on Monday May 15, 2023 by Thomson Reuters
5:44PM ET on Monday May 15, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PainReform Ltd | 5.1M | -0.6x | --- |
AgriFORCE Growing Systems Ltd | 5.0M | -0.4x | --- |
Gold River Productions Inc | 4.4M | 0.0x | --- |
Lexaria Bioscience Corp | 4.6M | -0.7x | --- |
Cannabis Suisse Corp | 3.5M | -9.9x | --- |
Nexien Biopharma Inc | 3.1M | -8.2x | --- |
Company Information
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Contact Information
- Headquarters
- 65 Yigal Alon St.TEL AVIV-YAFO, Israel 6744316
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Ehud Geller
- Chief Executive Officer, Chief Financial Officer
- Ilan Hadar
- Chief Operating Officer
- Sigal Aviel
- Chief Technology Officer, Director
- Eli Hazum
- Vice President - Pharmaceutical Operations
- Rita Keynan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.82 |
Book Value | $1.04 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
